FDA Clearance Tracker · K230794
Rebuilder Nerve Guidance Conduit
Last checked: Nov 20, 2026Latest source record: Jan 29, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 29, 2024
Substantially Equivalent
Time to decision
313 days
Received Mar 22, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K230794
- Device name
- Rebuilder Nerve Guidance Conduit
- Applicant
- Celestray Biotech Company, LLC.,
- Applicant location
- Bethesda, MD
- Received
- Mar 22, 2023
- Decided
- Jan 29, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Cuff, Nerve (JXI)
- Device class
- Class II
- Regulation
- 21 CFR 882.5275
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JXI. The earliest in FDA's data is K850785, decided Jul 10, 1985.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K230794
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Celestray Biotech Company, LLC.,
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K222220 · Decided Jul 6, 2023 · 346 days after receipt
Device type: Mesh, Surgical, Absorbable, Orthopaedics, Reinforcement Of Tendon (OWW) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.